These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30639583)

  • 1. microRNAs in chronic kidney disease.
    Zhao H; Ma SX; Shang YQ; Zhang HQ; Su W
    Clin Chim Acta; 2019 Apr; 491():59-65. PubMed ID: 30639583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of microRNAs in renal disorders related to primary podocyte dysfunction.
    Iranzad R; Motavalli R; Ghassabi A; Pourakbari R; Etemadi J; Yousefi M
    Life Sci; 2021 Jul; 277():119463. PubMed ID: 33862110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal microRNA- and RNA-profiles in progressive chronic kidney disease.
    Rudnicki M; Perco P; D Haene B; Leierer J; Heinzel A; Mühlberger I; Schweibert N; Sunzenauer J; Regele H; Kronbichler A; Mestdagh P; Vandesompele J; Mayer B; Mayer G
    Eur J Clin Invest; 2016 Mar; 46(3):213-26. PubMed ID: 26707063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease.
    Taïbi F; Metzinger-Le Meuth V; M'Baya-Moutoula E; Djelouat Ms; Louvet L; Bugnicourt JM; Poirot S; Bengrine A; Chillon JM; Massy ZA; Metzinger L
    Biochim Biophys Acta; 2014 Jan; 1842(1):88-98. PubMed ID: 24140891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT4 Expression in Primary and Secondary Kidney Diseases: Dependence on Staging.
    Kiewisz J; Skowronska A; Winiarska A; Pawlowska A; Kiezun J; Rozicka A; Perkowska-Ptasinska A; Kmiec Z; Stompor T
    Kidney Blood Press Res; 2019; 44(2):200-210. PubMed ID: 31067548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.
    Lv W; Fan F; Wang Y; Gonzalez-Fernandez E; Wang C; Yang L; Booz GW; Roman RJ
    Physiol Genomics; 2018 Jan; 50(1):20-34. PubMed ID: 29127220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Protein and Peptide Markers in Chronic Kidney Disease.
    Chebotareva N; Vinogradov A; McDonnell V; Zakharova NV; Indeykina MI; Moiseev S; Nikolaev EN; Kononikhin AS
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary miR-196a predicts disease progression in patients with chronic kidney disease.
    Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z
    J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in kidney physiology and disease.
    Trionfini P; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2015 Jan; 11(1):23-33. PubMed ID: 25385286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.
    Cardenas-Gonzalez M; Srivastava A; Pavkovic M; Bijol V; Rennke HG; Stillman IE; Zhang X; Parikh S; Rovin BH; Afkarian M; de Boer IH; Himmelfarb J; Waikar SS; Vaidya VS
    Clin Chem; 2017 Sep; 63(9):1515-1526. PubMed ID: 28667184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The research status and prospect of Periostin in chronic kidney disease.
    Jia YY; Yu Y; Li HJ
    Ren Fail; 2020 Nov; 42(1):1166-1172. PubMed ID: 33241962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.
    Peters LJF; Floege J; Biessen EAL; Jankowski J; van der Vorst EPC
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tubulointerstitial nephritis antigen expression in chronic kidney disease and its clinical significance].
    Yang Y; Xiao L; Xu X; Yang D; Zhu X; Hu P; Sun L
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(4):246-50. PubMed ID: 24731487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
    Freedman BI; Limou S; Ma L; Kopp JB
    Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S8-S16. PubMed ID: 30343724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.
    Nassirpour R; Raj D; Townsend R; Argyropoulos C
    Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread.
    Duni A; Liakopoulos V; Roumeliotis S; Peschos D; Dounousi E
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Expression of miR-21 in Kidney Tissue of Dogs With X-Linked Hereditary Nephropathy: A Canine Model of Chronic Kidney Disease.
    Clark SD; Song W; Cianciolo R; Lees G; Nabity M; Liu S
    Vet Pathol; 2019 Jan; 56(1):93-105. PubMed ID: 30370838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases.
    Bhatt K; Kato M; Natarajan R
    Am J Physiol Renal Physiol; 2016 Jan; 310(2):F109-18. PubMed ID: 26538441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.